Cancelas Jose A
UNIVERSITY OF CINCINNATI.
Blood. 2015 Oct 29;126(18):2082-3. doi: 10.1182/blood-2015-09-669085.
In this issue of , Price et al report the results of a phase 3 prospective randomized trial comparing the clinical outcome of infected, severely neutropenic patients after receiving or not receiving granulocyte transfusions.
在本期杂志中,普赖斯等人报告了一项3期前瞻性随机试验的结果,该试验比较了感染的严重中性粒细胞减少患者接受或未接受粒细胞输注后的临床结局。